Latest News

INTERVENTIONAL
POSTED BY CARA SCHILLINGER ON 9/24/2012

Recruitment complete for two pivotal Phase III studies of nintedanib* in patients with idiopathic pulmonary fibrosis

24th September 2012 13:16 IST
Ingelheim, Germany (Business Wire (Business Wire India))

For NON-U.S Health Media Only

INTERVENTIONAL
POSTED BY CARA SCHILLINGER ON 9/20/2012

Thalidomide Eases Cough in Lung Fibrosis Patients

INTERVENTIONAL
POSTED BY CARA SCHILLINGER ON 9/10/2012

FIBROGEN ANNOUNCES PRESENTATION OF UPDATED RESULTS AT EUROPEAN RESPIRATORY SOCIETY ANNUAL CONGRESS

San Francisco, CA - September 5, 2012

INTERVENTIONAL
POSTED BY CARA SCHILLINGER ON 9/4/2012

InterMune Reports New Analyses from the RECAP Study of Esbriet® (pirfenidone) at ERS

INVESTIGATIONAL
POSTED BY CARA SCHILLINGER ON 9/1/2012

Idiopathic pulmonary fibrosis: new evidence and an improved standard of care in 2012

Ganesh Raghu, MD

Lancet 2012; 380: 699–701
Division of Pulmonary and Critical Care Medicine, University of Washington Medical Center, University of Washington, Seattle, WA, USA (Prof G Raghu MD)
Correspondence to:
Prof Ganesh Raghu, Box 356175, 1959 Pacific Avenue, Seattle, WA 98195, USA